Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChanghai Hospital
About this trial
A prospective, multicenter, randomized controlled, open-label, blinded endpoint evaluation study.
Eligibility criteria
Qualifiers
Age 18 or above；
Patients with a clear history of head trauma and confirmed acute epidural hematoma by head CT；
Cases that the case screening committee deems suitable for conservative treatment*；
Randomly within 6 hours after injury, and initiate treatment within 8 hours after injury；
Disqualifiers
Patients who require craniotomy surgery to remove hematoma；
Bilateral acute epidural hematoma；
Combined severe acute subdural hematoma；
Brainstem injury；
Trial design
Treatments tested in this trial
- MMA embolization plus medical therapy
- Medical therapy alone
Treatment groups
194 Participants
are divided into 2 treatment groupsSponsors and collaborators
Changhai Hospital
Lead sponsor
The First People's Hospital of Changzhou
Collaborator
Source ClinicalTrials.gov